186 related articles for article (PubMed ID: 11480400)
1. EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences.
Tucker GT; Houston JB; Huang SM
Eur J Pharm Sci; 2001 Jul; 13(4):417-28. PubMed ID: 11480400
[No Abstract] [Full Text] [Related]
2. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--towards a consensus.
Tucker GT; Houston JB; Huang SM
Br J Clin Pharmacol; 2001 Jul; 52(1):107-17. PubMed ID: 11453898
[No Abstract] [Full Text] [Related]
3. Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development.
Rolan P; Atkinson AJ; Lesko LJ; ;
Clin Pharmacol Ther; 2003 Apr; 73(4):284-91. PubMed ID: 12709718
[No Abstract] [Full Text] [Related]
4. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus.
Tucker GT; Houston JB; Huang SM
Pharm Res; 2001 Aug; 18(8):1071-80. PubMed ID: 11587475
[No Abstract] [Full Text] [Related]
5. 6th European Congress of Pharmaceutical Sciences, EUFEPS 2000. September 16-19, 2000. Budapest, Hungary. Abstracts.
Eur J Pharm Sci; 2000 Sep; 11 Suppl 1():S1-135. PubMed ID: 11109934
[No Abstract] [Full Text] [Related]
6. Getting the Dose Right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug development.
Stanski DR; Rowland M; Sheiner LB
J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):199-211. PubMed ID: 16283539
[TBL] [Abstract][Full Text] [Related]
7. Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences.
Mochel JP; Tyden E; Hellmann K; Vendrig JC; Şenel S; Dencker L; Cristina RT; Linden H; Schmerold I
J Vet Pharmacol Ther; 2018 Jun; 41(3):378-383. PubMed ID: 29266320
[TBL] [Abstract][Full Text] [Related]
8. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus.
Tucker GT; Houston JB; Huang SM
Clin Pharmacol Ther; 2001 Aug; 70(2):103-14. PubMed ID: 11503003
[No Abstract] [Full Text] [Related]
9. [Transporter-mediated drug-drug interaction in renal and hepatic elimination processes].
Nagai J
Nihon Yakurigaku Zasshi; 2010 Jan; 135(1):34-7. PubMed ID: 20075569
[No Abstract] [Full Text] [Related]
10. Role of drug metabolism in drug research and development: view of a medicinal chemist.
Clarke FH
J Pharm Sci; 1972 Oct; 61(10):1678-82. PubMed ID: 5072431
[No Abstract] [Full Text] [Related]
11. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
Soars MG; Webborn PJ; Riley RJ
Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
[TBL] [Abstract][Full Text] [Related]
12. Integrating systems approaches into pharmaceutical sciences.
Westerhoff HV; Mosekilde E; Noe CR; Clemensen AM
Eur J Pharm Sci; 2008 Sep; 35(1-2):1-4. PubMed ID: 18602464
[TBL] [Abstract][Full Text] [Related]
13. Perspectives of pharmacokinetics and metabolism in drug design.
Hsieh Y
Curr Pharm Des; 2009; 15(19):2169. PubMed ID: 19601820
[No Abstract] [Full Text] [Related]
14. March of the synthesis machines.
Sanderson K
Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
[No Abstract] [Full Text] [Related]
15. Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability.
Nassar AE; Kamel AM; Clarimont C
Drug Discov Today; 2004 Dec; 9(23):1020-8. PubMed ID: 15574318
[TBL] [Abstract][Full Text] [Related]
16. General aspects of the registration of geriatric drugs.
Rondel RK
Gerontology; 1982; 28 Suppl 2():49-58. PubMed ID: 7166239
[No Abstract] [Full Text] [Related]
17. The pharmaceutical sciences in 2020--report of a conference organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP).
Shah VP; Besançon LJ; Stolk P; Tucker G; Crommelin DJ
Eur J Pharm Sci; 2009 Dec; 38(5):419-25. PubMed ID: 19651208
[TBL] [Abstract][Full Text] [Related]
18. Editorial: metabolism and drug-drug interaction potential of biotherapeutics.
Li AP
Curr Drug Metab; 2012 Sep; 13(7):881. PubMed ID: 22475272
[No Abstract] [Full Text] [Related]
19. Process chemistry: The science, business, logic, and logistics.
Zhang TY
Chem Rev; 2006 Jul; 106(7):2583-95. PubMed ID: 16836293
[No Abstract] [Full Text] [Related]
20. Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.
Wang R; Conner DP; Li BV
AAPS J; 2017 Mar; 19(2):360-366. PubMed ID: 28004346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
